Prospective observational study of antiphospholipid antibodies in acute lung injury and acute respiratory distress syndrome: comparison with catastrophic antiphospholipid syndrome

Abstract

Detection of antiphospholipid (aPL) antibodies in bronchoalveolar lavage fluid (BALF) of patients with acute respiratory distress syndrome (ARDS) suggests involvement of autoimmune mechanisms in the pathogenesisof ARDS. We investigated whether aPL antibodies could be detected in the serum as well as BALF of patients with acute lung injury (ALI) and ARDS. IgG anticardiolipin, IgG anti-b2-glycoproteinI, IgG antiphosphatidicacid and IgG antiphosphatidylserineantibodieswere detected by ELISA in low titers within the normal range in the BALF and serum of nine patients with ALI and 17 patients with ARDS. However, one out of 27 patients investigatedhad high levelsof aPL antibodies in both BALF and serum. This patient suffered from severe ARDS due to sepsis. The high aPL antibodylevels in serum possibly triggered by sepsis were associated with high aPL antibody levels in BALF, which can be explained by high capillary-alveolar permeability. Computed tomography scan revealed widespread infarctions in brain, spleen and kidneys, and pulmonary thromboembolism, suggesting the diagnosis of catastrophic antiphospholipid syndrome.

Keywords

acute lung injury acute respiratory distress syndrome antiphospholipid antibodies bronchoalveolar lavage fluid catastrophic antiphospholipid syndrome

Get full access to this article

View all access options for this article.

References

Welty-WolfKE , Carraway MS , Ortel TL , PiantodosiCA. Coagulationand inflammation in acute lung injury . Thromb Haemost 2002; 88: 17-25 .

Asherson RA. The catastrophic antiphospholipidsyndrome . J Rheumatol 1992; 19: 508-512 .

Asherson RA , Cervera R , Piette JC et al. Catastrophic antiphospholipid syndrome: clues to the pathogenesis from a series of 80 patients . Medicine (Baltimore) 2001; 80: 355-377 .

Asherson RA , Cervera R , Piette JC et al. Catastrophic antiphospholipid syndrome. Clinical and laboratory features of 50 patients . Medicine (Baltimore) 1998; 77: 195-207 .

Asherson RA , Cervera R. Review: antiphospholipid antibodies and the lung . J Rheumatol 1995; 22: 62-66 .

Wyncoll DLA , Evans TW. Acute respiratory distress syndrome . Lancet 1999; 354: 497-501 .

Ware LB , Matthay MA. The acute respiratory distress syndrome . N Engl J Med 2000; 342: 1334-1349 .

Maneta-Peyret L , Kitsiouli E , Lekka M , Nakos G , Cassagne C. Autoantibodies to lipids in bronchoalveolar lavage fluid of patients with acute respiratory distress syndrome . Crit Care Med 2001; 29: 1950-1954 .

Wiedermann FJ , Mayr A , Schobersberger W et al. Acute respiratory failure associated with catastrophic antiphospholipidsyndrome . J Intern Med 2000; 247: 723-730 .

10.

Bernard GR , Artigas A , Brigham KL et al. The American-European consensus conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial coordination . Am J Respir Crit Care Med 1994; 149: 818-824 .

11.

Rennard SI , Basset G , Lecossier D et al. Estimation of volume of epithelial lining fluid recovered by lavage using urea as a marker of dilution . J Appl Physiol 1986; 60: 532-538 .

12.

Levine JS , Ware Brach D , Rauch J. The antiphospholipid syndrome . N Engl J Med 2002; 346: 752-763 .

13.

Shi W , Krilis SA , Chong BH , Gordon S , Chesterman CN. Prevalence of lupus anticoagulant and anticardiolipin antibodies in a healthy population . Aust NZ J Med 1990; 20: 231-236 .

14.

Lewis S , Keil LB , Binder WL , DeBari VA. Standardized measurement of major immunoglobulin class (IgG, IgA, and IgM) antibodies to β2 glycoprotein I in patients with antiphospholipidsyndrome . J Clin Lab Anal 1998; 12: 293-297 .

15.

Wenzel C , Stoiser B , Locker GJ et al. Frequent development of lupus anticoagulants in critically ill patients treated under intensive care conditions . Crit Care Med 2002; 30: 763-770 .

16.

Dalekos GN , Zachou K , Liaskos C. The antiphospholipidsyndrome and infection . Curr Rheumatol Rep 2001; 3: 277-285 .

17.

Rojas-Rodriguez J , Garcia-Carrasco M , Ramos-Casals M et al. Catastrophic antiphospholipid syndrome: clinical description and triggering factors in 8 patients . J Rheumatol 2000; 27: 238-240 .

18.

Harats D , George J. β2-glycoprotein I and atherosclerosis . Curr Opin Lipidol 2001; 12: 543-546 .

19.

Glueck CJ , Lang JE , Tracy T , Sieve-Smith L , Wang P. Evidence that anticardiolipin antibodies are independent risk factors for atherosclerotic vascular disease . Am J Cardiol 1999; 83: 1490-1494 .

20.

Asherson RA. Antiphospholipid antibodies, malignancies and paraproteinemias . J Autoimmunity 2000; 15: 117-122 .

21.

Holter JF , Weiland JE , Pacht ER , Gadek JE , Davis WB. Protein permeability in the adult respiratory distress syndrome: loss of size selectivity of the alveolar epithelium . J Clin Invest 1986; 78: 1513-1522 .

22.

Kitz R , Ahrens P , Zielen S. Immunoglobulin levels in bronchoalveolar lavage fluid of children with chronic chest disease . Pediatr Pulmonol 2000; 29: 443-451 .

23.

Fahy RJ , Diaz PT , Hart J , Wewers MD. BAL and serum IgG levels in healthy asymptomatic HIV-infected patients . Chest 2001; 119: 196-203 .